Studying the effecf of oral minoxidil on androgenetic hair loss
Phase 3
Recruiting
- Conditions
- Androgenetic alopecia.Androgenic alopecia, unspecifiedL64.9
- Registration Number
- IRCT20221101056366N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 50
Inclusion Criteria
Age above 18 years
AGA patients based on clinical examination and trichoscopy
Male gender
Patients with grade3 to 5 according to Hamilton's classification for male pattern hair loss
Exclusion Criteria
Another treatments for hair loss in the last 3 months
Alcohol and drug use
High blood pressure
Heart disease
Allergy to study drugs
Severe liver and kidney diseases
Simultaneous use of other AGA treatments
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total hair density, hair thickness,and the total number of vellus and terminal hairs. Timepoint: before the start of the study and 1, 2, 3 ,6 months after the start of the study. Method of measurement: Using digital video trichoscope and photography.
- Secondary Outcome Measures
Name Time Method Total hair density per centimeter square, hair thickness, number of hairs per follicular unit and patient's quality of life based on DLQI. Timepoint: 1, 2, 3 ,6 months after the initiation of the study. Method of measurement: Using a digital video trichoscope.